Assure (IONM) Competitors

BIOLASE (NASDAQ:BIOL) and Assure (NASDAQ:IONM) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, risk, earnings, valuation, institutional ownership, community ranking and dividends.

Which has more risk and volatility, BIOL or IONM?

BIOLASE has a beta of 0.67, indicating that its share price is 33% less volatile than the S&P 500. Comparatively, Assure has a beta of 1.91, indicating that its share price is 91% more volatile than the S&P 500.

Does the MarketBeat Community prefer BIOL or IONM?

BIOLASE received 289 more outperform votes than Assure when rated by MarketBeat users. Likewise, 52.42% of users gave BIOLASE an outperform vote while only 27.27% of users gave Assure an outperform vote.

Company	Underperform	Outperform
BIOLASE	Outperform Votes 292 52.42%	Underperform Votes 265 47.58%
Assure	Outperform Votes 3 27.27%	Underperform Votes 8 72.73%

Which has stronger earnings & valuation, BIOL or IONM?

BIOLASE has higher revenue and earnings than Assure.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BIOLASE	$48.83M	0.01	-$20.63M	-$14.94	0.00
Assure	$250K	0.13	-$26.08M	N/A	N/A

Do analysts rate BIOL or IONM?

BIOLASE currently has a consensus price target of $1.20, indicating a potential upside of 13,383.15%. Given BIOLASE's stronger consensus rating and higher probable upside, analysts clearly believe BIOLASE is more favorable than Assure.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BIOLASE	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Assure	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Does the media refer more to BIOL or IONM?

In the previous week, BIOLASE and BIOLASE both had 1 articles in the media. Assure's average media sentiment score of 0.76 beat BIOLASE's score of 0.00 indicating that Assure is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BIOLASE	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Assure	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals and insiders hold more shares of BIOL or IONM?

8.8% of BIOLASE shares are held by institutional investors. Comparatively, 3.3% of Assure shares are held by institutional investors. 0.3% of BIOLASE shares are held by company insiders. Comparatively, 3.8% of Assure shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Is BIOL or IONM more profitable?

BIOLASE has a net margin of -41.65% compared to Assure's net margin of -25,178.32%. Assure's return on equity of 0.00% beat BIOLASE's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BIOLASE	-41.65%	-1,782.73%	-55.31%
Assure	-25,178.32%	N/A	-249.78%

Summary

BIOLASE beats Assure on 10 of the 15 factors compared between the two stocks.